SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Suven Life Sciences - Quaterly Results

30 Jan 2024 Evaluate
Net sales declined -18.35%  to  Rs. 24.51 million from Rs. 30.02 millions.The Net Loss for the quarter ended December 2023 is Rs. -47.69 millions as compared to Net Loss of Rs. -66.33 millions of corresponding quarter ended December 2022 Operating profit Margin for the quarter ended December 2023 improved to -31.33% as compared to -48.98% of corresponding quarter ended December 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 24.51 30.02 -18.35 93.08 109.27 -14.82 135.39 118.44 14.31
Other Income 60.66 22.05 175.10 168.48 28.47 491.78 84.49 16.01 427.73
PBIDT -31.33 -48.98 -36.04 -72.22 -187.72 -61.53 -192.95 -350.41 -44.94
Interest 0.35 0.64 -45.31 1.28 2.35 -45.53 2.89 5.30 -45.47
PBDT -31.68 -49.62 -36.15 1.07 -130.07 -100.82 -135.84 -318.55 -57.36
Depreciation 16.01 16.71 -4.19 49.92 48.72 2.46 65.43 43.93 48.94
PBT -47.69 -66.33 -28.10 -48.85 -178.79 -72.68 -201.27 -362.48 -44.47
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -47.69 -66.33 -28.10 -48.85 -178.79 -72.68 -201.27 -362.48 -44.47
Equity 218.07 218.07 0.00 218.07 218.07 0.00 218.07 145.38 50.00
PBIDTM(%) -127.83 -163.16 -21.66 -77.59 -171.79 -54.84 -142.51 -295.85 -51.83

Suven Life Sciences Share Price

194.65 16.35 (9.17%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×